Ted W. Love - 25 Jun 2021 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
Director
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Ted W. Love
Issuer symbol
RPRX
Transactions as of
25 Jun 2021
Net transactions value
$0
Form type
4
Filing time
29 Jun 2021, 20:43:54 UTC
Previous filing
18 May 2021
Next filing
24 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Award $0 +5,726 +33% $0.000000 22,866 25 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.
F2 Reflects an adjustment to the number of Class A Ordinary Shares beneficially owned by the reporting person based on the actual number of shares delivered to the reporting person upon the settlement of an award of restricted stock units granted to the reporting person as reported on August 13, 2020.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney